B
한국비티비
219750KOSDAQ57.0 / 100
Reference Date: 2026-10-23
Financial Score14.5 / 40
News Sentiment12.5 / 25
Momentum20.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 53.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Hanbitbi, established in 1999, is a medical device and biotechnology company that merged with Dongin Biotech in 2024, rebranding as Hanbitbi. Its Medical Device Division produces and sells anti-aging and beauty devices, including home beauty equipment, while the Bio Business Division supplies research reagents and equipment to biotech industries.
Number of Employees
100people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.38Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
-14.97Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
54.19Industry Average 100.005.0Point
Lower than industry avg (good)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲511.6% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼137.6% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -177.3% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position8.0Point
Near 52w high (84%, uptrend)
Current 2,570Won52-week high 2,93052-week low 571
1-month return6.0Point
1m +53.25% (strong rise)
Volume trend6.0Point
Volume surge
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0